Mid-infrared spectroscopy of serum, a promising non-invasive method to assess prognosis in patients with ascites and cirrhosis.

Maëna Le CorvecCaroline JezequelValérie MonbetNadia FatihFrédéric CharpentierHugues TarielCatherine Boussard-PlédelBruno BureauOlivier LoréalOlivier SireEdouard Bardou-Jacquet

Published in: PloS one (2017)

In this pilot study MIR-FEWS more accurately assess the 6-month prognosis of patients with ascites and cirrhosis than the MELD or Child-Pugh scores. These promising results, if confirmed by a larger study, suggest that mid infrared spectroscopy could be helpful in the management of these patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
long non coding rna
cell free
mental health
prognostic factors
long noncoding rna